Zobrazeno 1 - 10
of 10
pro vyhledávání: '"N F, Paoni"'
Publikováno v:
Circulation. 92:3032-3040
Background The thrombolytic properties of a new variant of tissue plasminogen activator (TPA) (T103N, N117Q, KHRR 296-299 AAAA, or TNK-TPA) with longer plasma half-life, greater fibrin specificity, and increased resistance to inhibition by plasminoge
Publikováno v:
Thrombosis and haemostasis. 75(5)
Multiple clinical trials have proven that thrombolytic therapy is an effective treatment for acute myocardial infarction. Spontaneous intracranial hemorrhage (ICH) occurs in a small percentage of patients as a result of the treatment. The etiology of
Publikováno v:
Thrombosis and haemostasis. 75(1)
Inactivation by slow acting inhibitors in plasma is of little consequence for thrombolysis with wild type t-PA, since it is rapidly cleared from the blood stream and constantly replenished through infusion. However, it becomes increasingly important
Autor:
J Lai, Luis C. Pena, L. Berleau, Bruce Keyt, C Pater, J Ogez, C J Refino, Alice M. Chow, N F Paoni, Hung V. Nguyen
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 91(9)
Current treatment with tissue plasminogen activator (tPA) requires an intravenous infusion (1.5-3 h) because the clearance of tPA from the circulation is rapid (t 1/2 approximately 6 min). We have developed a tPA variant, T103N,N117Q, KHRR(296-299)AA
Autor:
C J, Refino, N F, Paoni, B A, Keyt, C S, Pater, J M, Badillo, F M, Wurm, J, Ogez, W F, Bennett
Publikováno v:
Thrombosis and haemostasis. 70(2)
In the accompanying paper, we reported that the properties of decreased plasma clearance rate, increased fibrin specificity, and resistance to inactivation by PAI-1 could be effectively combined in the t-PA variant T103N, KHRR 296-299 AAAA. In the cu
Autor:
N F, Paoni, B A, Keyt, C J, Refino, A M, Chow, H V, Nguyen, L T, Berleau, J, Badillo, L C, Peña, K, Brady, F M, Wurm
Publikováno v:
Thrombosis and haemostasis. 70(2)
Site directed mutagenesis was used to construct a t-PA variant that contains an additional glycosylation site in the first kringle domain (T103N) combined with a tetra-alanine substitution in the protease domain (KHRR 296-299 AAAA). This combination
Autor:
W F, Bennett, N F, Paoni, B A, Keyt, D, Botstein, A J, Jones, L, Presta, F M, Wurm, M J, Zoller
Publikováno v:
The Journal of biological chemistry. 266(8)
Sixty-four variants of human tissue-type plasminogen activator (tPA) were produced using recombinant DNA techniques. Charged residues were converted to alanine in clusters of from one to four changes per variant; these clusters spanned all the domain
Publikováno v:
The Journal of biological chemistry. 252(21)
Two major forms of native sheep plasminogen (SPg-a) have been isolated from plasma by affinity chromatography. These forms differ in molecular weight, charge characteristics, affinity for epsilon-aminocaproic acid (epsilon-Ahx), and carbohydrate cont
Autor:
R L Arroyo, N F Paoni
An assay has been developed to detect bacterial glycosidases in colonies grown on the surface of agar plates. Advantages of this technique over previously described methods include elimination of the need for replica plating, better visualization of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8940d7b241b5d829a46962f31180fe1b
https://europepmc.org/articles/PMC239639/
https://europepmc.org/articles/PMC239639/
Autor:
N F, Paoni, F J, Castellino
Publikováno v:
The Journal of biological chemistry. 254(6)